The Evolution of Clinical Care
By Barbara Buck, Principal Clinical Project Manager at Cochlear Americas There have been dramatic changes to cochlear implants and the way professionals deliver care over the past 30 years. In […]
Get the latest clinical and surgical news about the Nucleus® Systems, cochlear implant candidacy, reliability, hearing loss and more. Check it out!
Journal Club – Slim, Modiolar Cochlear Implant Electrode: Melbourne Experience and Comparison With the Contour Perimodiolar Electrode
By Wade Colburn, Biomedical Engineer and Product Manager – Implants, Cochlear Americas Slim, Modiolar Cochlear Implant Electrode: Melbourne Experience and Comparison With the Contour Perimodiolar Electrode1 Chanan Shaul, Stefan Weder, […]
Cochlear obtains FDA approval of Kanso 2 Sound Processor, first off-the-ear cochlear implant sound processor with direct smartphone connectivity
We are excited to announce that Cochlear has received the U.S. Food and Drug Administration’s (FDA) approval of the new Cochlear™ Nucleus® Kanso® 2 off-the-ear Sound Processor (CP1150). We have […]
Guide to Cochlear’s new expanded pediatric indication
On March 17, 2020, Cochlear received FDA approval to lower the age of cochlear implantation from 12 months to 9 months for children with bilateral, profound sensorineural hearing loss. Here […]
Connecting with patients during COVID-19: Q&A with Alison Vega, AuD
Alison Vega, audiologist and Owner of Ascent Audiology & Hearing, discusses her 20 years of audiology experience and how her personal patient care has evolved in the current healthcare landscape. […]
New TECH Talk: Early implantation and its impact on language development
In March 2020 the FDA approved the first expansion of pediatric indications in 20 years. Dr. Jace Wolfe, Director of Audiology and Research at the Hearts for Hearing Foundation in […]
Dr. Herzog discusses resuming implant surgeries and first impressions of recent product innovations
By Patti Trautwein, MA, AuD, Vice President, Marketing at Cochlear Americas Jacques Herzog, MD of Washington University School of Medicine in St. Louis, answers questions about resuming implant surgeries and […]
Journal Club: Development of a 60/60 Guideline for Referring Adults for a Traditional Cochlear Implant Candidacy Evaluation
By Duncan Meldrum, Senior Manager of Professional Engagement at Cochlear Development of a 60/60 Guideline for Referring Adults for a Traditional Cochlear Implant Candidacy Evaluation Zwolan, Teresa A.; Schvartz-Leyzac, Kara […]
Cochlear’s Latest Reliability Reporting Further Demonstrates Commitment to Quality
By Ryan Lopez, Director, Nucleus® Product Management & Marketing at Cochlear Americas Quality products start with Cochlear’s commitment to putting recipients first and expanding access to information to reinforce transparency. […]
University of Iowa resumes CI operations and implants world’s first Cochlear™ Nucleus® Profile™ Plus with Slim 20 Electrode
By Wade Colburn, Product Manager – Cochlear Implants Early in the COVID-19 crisis, widespread uncertainty led to clinic visits and surgeries being postponed or cancelled until further notice. While the […]
End of content
No more pages to load